Stockreport

NRx Pharmaceuticals Eyes First Commercial Revenue in 2024, Announces Breakthroughs in Bi-Annual Milestone Update [Yahoo! Finance]

NRX Pharmaceuticals, Inc.  (NRXP) 
PDF therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. NRXP is d [Read more]